Answers are grounded in this paper and cite their sources.
In our previous review we reviewed the history of embryonic stem cells, advantages and disadvantages of ESC, parthenogenetic ESC and their therapeutic applications, cloning along with merits of SCNT, in this shot commentary we have just concentrated on induced pluripotent stem cells, mainly their transcriptomics, along with special emphasis on global transcriptomics in candidate oocyte factors and various advances in therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: